ABSTRACT
The aim of this study was to determine the association of the type of social support and proactive coping with depressive symptoms (DS) in Japanese people living with human immunodeficiency virus (PLHIV), in order to select effective psychosocial care or intervention. Questionnaires were anonymously collected from randomly recruited participants. The questionnaire included items on demographic characteristics, HIV treatment-related factors, DS, social support, and coping. Hierarchical binary logistic regression was used to identify factors associated with DS. A total of 564 patients completed the questionnaire and 207 (37%) patients reported DS. Demographic factors, such as drug-use-related disorders [adjusted odds ratio (AOR) 7.21, 95% confidence interval (95%CI) 1.95–26.70], unemployment (AOR 3.06, 95%CI 1.50–6.27) and younger age (AOR 0.96, 95%CI 0.94–0.99) were significantly associated with DS. With regard to coping, higher levels of instrumental support seeking (AOR 1.09, 95%CI 1.01–1.18), lower levels of proactive coping (AOR 0.91, 95%CI 0.87–0.96) and lower levels of emotional support seeking (AOR 0.82, 95%CI 0.72–0.92) were significantly associated with DS. Our results highlight the need for psychosocial care to enhance or compensate proactive coping and emotional support seeking abilities in DS. Healthcare workers should pay attention to the mental health of young unemployed PLHIV with drug-use-related disorders.
Acknowledgments
The authors express special thanks to all the staff of the AIDS Clinical Center, National Center for Global Health and Medicine, especially Kiyoto Tsuchiya, Junko Tanuma, Syoko Matsumoto, Haruko Hoshino, Atsumi Saijyo, Kumiko Toyama, Tsuwasa Sakurai, Michiko Hatano, Ai Takahashi, Yoshimi Kikuchi, Hiroyuki Gatanaga, Katsuji Teruya, Kunihisa Tsukada, Koji Watanabe, Takahiro Aoki, Daisuke Mizushima, Yasuaki Yanagawa, Haruka Uemura, Naokatsu Ando, Daisuke Shiojiri, Hirohisa Yazaki, Ikumi Genka, Kazuko Ikeda, Miwa Ogane, Yuko Sugino, Beni Taniguchi, Hitomi Suzuki, Asami Kurita, Naomi Abe, Hukuko Osugi, Akane Soldano, Yoshimi Abe.
Disclosure statement
S.O. received honararium for lectures from MSD, Janssen Pharmaceutical, Gilead Sciences and research grants from MSD, ViiV Healthcare, and Gilead Sciences. Other authors declare no conflict of interest.